Kodak Pivots to Drug Production with $765M US Loan, Stock Skyrockets
Kodak’s stock skyrocketed severalfold today, and it had nothing to do with the company’s long-established business in the world of photography. News broke that Kodak had secured at $765 million loan from the US government to shift its attention to producing ingredients for generic drugs. petapixel.com »